Discussion Pancreatic Cancer Abstracts 145, LBA146, 147, & LBA148 Philip Agop Philip, MD, PhD, FRCP Karmanos Cancer Center Wayne State University Detroit,
Results of a Randomized Phase III Trial (MPACT) of Weekly nab-Paclitaxel Plus Gemcitabine vs Gemcitabine Alone for Patients With Metastatic Adenocarcinoma.
